Other
Tonsillectomy
0
Pipeline Programs↗
4
Active Trials↗
1
Companies Involved↗
Tonsillectomy is an early-stage landscape with 0 programs across 1 company. The most active players are Pacira Pharmaceuticals, Inc.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
67
clinical trials
Completed40 · 60%
Terminated12 · 18%
Unknown status8 · 12%
Recruiting3 · 4%
Withdrawn3 · 4%
Not yet recruiting1 · 1%
Clinical Trials
Trial Activity
67 trials
Optimization of Pediatric Tonsillectomy to IMprove AnaLgesia
Recruiting·—·Phase 4·NCT06576830·440 enrolled
Melatonin vs Midazolam in Children Undergoing Tonsillectomy
Not yet recruiting·—·Phase 3·NCT07336095·195 enrolled
Magnesium vs Placebo for Tonsillectomy
Completed·—·Phase 2/3·NCT02218424·60 enrolled
Celecoxib After Tonsillectomy
Completed·—·Phase 2·NCT02934191·172 enrolled
An Approach to Reduce Uvula Edema After Tonsillectomy
Completed·—·Phase 4·NCT03079453·30 enrolled
Page 1 of 5
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)